News ArchivesRead News
Implanted eye cells eased Parkinson’s
Thursday December 22, 2005
December 19, 2005(Reuters Health) - A handful of people with Parkinson’s disease showed marked improvement after surgeons implanted in their brains chemical-producing cells taken from the eye of a dead donor, researchers said last week.
Cells from the inner, or pigment, layer of the eye’s retina make levodopa, which Parkinson’s patients commonly take in pill form to replace lost production of the neurotransmitter dopamine.
Dopamine allows the brain to control the body’s movements.
For most patients, levodopa pills lose their effectiveness within five years, and larger and larger doses are needed to curb the involuntary movements and shaking symptomatic of the disease.
Many people on the drug develop involuntary writhing or dance-like movements.
The retina cells were cultivated and implanted in the brains of six patients with advanced Parkinson’s, researcher Natividad Stover of the University of Alabama said.
One year later, the patients scored 48 percent higher on tests of movement and coordination, and the improvement was sustained after two years, Stover wrote in the journal Archives of Neurology.
’’The implants were well tolerated," the report said. Improvement was also observed in daily living and quality of life.
Parkinson’s is a degenerative disease in which key brain cells that produce dopamine die off. Symptoms start with tremors and rigidity, and patients can end up paralyzed. The cause of the disease, which attacks 2 percent of men and 1.3 percent of women, is unknown, and there is no cure.
Some scientists have viewed implanting fetal stem cells into the brains of Parkinson’s patients as a promising avenue to restore dopamine production. But preliminary human trials were disappointing, and animal experiments have yielded mixed results.
Other treatments showing promise include deep brain stimulation with implanted electrodes, drugs that promote brain cell growth, and gene therapy.
The researchers said a larger study has been started to test the efficacy and safety of retina cell implants.
Recent NewsOct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 18 - Fighting Parkinson's disease through dance
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show